MCRB peer analysis
Seres Therapeutics (MCRB) against its competitors: price, today's move, 1-year return and market value side by side.
- MCRB's peers: ABOS (Acumen Pharmaceuticals), ACTU (Actuate Therapeutics), CGTX (Cognition Therapeutics), HURA (TuHURA Biosciences), INO (Inovio Pharmaceuticals), IRD (Opus Genetics), SEER (Seer), SPRO (Spero Therapeutics).
MCRB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals | $0.18 | -9.11% | -88.66% | $12.71M |
| ACTU Actuate Therapeutics | $0.21 | -12.95% | -96.35% | $5.13M |
| CGTX Cognition Therapeutics | $0.60 | 0.10% | -56.79% | $57.12M |
| HURA TuHURA Biosciences | $1.36 | -0.73% | -22.29% | $89.43M |
| INO Inovio Pharmaceuticals | $1.84 | 7.60% | 3.37% | $127.13M |
| IRD Opus Genetics | $3.87 | -5.17% | 108.01% | $373.95M |
| SEER Seer | $1.39 | -3.82% | -30.75% | $77.30M |
| SPRO Spero Therapeutics | $0.83 | -5.46% | -65.28% | $48.14M |
| VTGN Vistagen Therapeutics | $0.19 | -6.47% | -95.85% | $8.62M |
| MCRB Seres Therapeutics | $1.33 | -7.64% | -95.35% | $13.56M |